These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 6129556)

  • 1. Blockade of alpha-adrenergic receptors by analogues of phosphatidylcholine.
    Smith KA; Cornett LE; Norris JS; Byers LW; Muirhead EE
    Life Sci; 1982 Nov; 31(18):1891-902. PubMed ID: 6129556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analogs of phosphatidylcholine: alpha-adrenergic antagonists from the renal medulla.
    Smith KA; Prewitt RL; Byers LW; Muirhead EE
    Hypertension; 1981; 3(4):460-70. PubMed ID: 6118327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antihypertensive lipids from the kidney: alkyl ether analogs of phosphatidylcholine.
    Muirhead EE; Byers LW; Desiderio DM; Brooks B; Brosius WM
    Fed Proc; 1981 Jun; 40(8):2285-90. PubMed ID: 7016598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of antihypertensive polar renomedullary lipid in the pathogenesis of hypertension.
    Masugi F; Ogihara T; Otsuka A; Saeki S; Kumahara Y
    Jpn Circ J; 1984 Feb; 48(2):196-200. PubMed ID: 6366289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atropine lowers blood pressure in normotensive rats through blockade of alpha-adrenergic receptors.
    Abraham S; Cantor EH; Spector S
    Life Sci; 1981 Jan; 28(3):315-22. PubMed ID: 6111727
    [No Abstract]   [Full Text] [Related]  

  • 6. Vasodilatation elicited by 5-HT1A receptor agonists in constant-pressure-perfused rat kidney is mediated by blockade of alpha 1A-adrenoceptors.
    Eltze M; Boer R; Sanders KH; Kolassa N
    Eur J Pharmacol; 1991 Sep; 202(1):33-44. PubMed ID: 1686254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of alpha adrenergic receptor stimulation on integrated systemic venous bed.
    Müller-Ruchholtz ER; Lösch HM; Grund E; Lochner W
    Pflugers Arch; 1977 Sep; 370(3):241-6. PubMed ID: 22062
    [No Abstract]   [Full Text] [Related]  

  • 8. Alpha 2-adrenergic receptors and calcium: alpha 2-receptor blockade in vascular smooth muscle as an approach to the treatment of hypertension.
    Lee JY; DeBernardis JF
    Methods Find Exp Clin Pharmacol; 1990 Apr; 12(3):213-25. PubMed ID: 1972206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [3H]Dihydroergocryptine binding to alpha adrenergic receptors in canine aortic membranes.
    Tsai BS; Lefkowitz RJ
    J Pharmacol Exp Ther; 1978 Mar; 204(3):606-14. PubMed ID: 24730
    [No Abstract]   [Full Text] [Related]  

  • 10. Interaction between alpha adrenergic and serotonergic activation of canine saphenous veins.
    Curro FA; Greenberg S; Verbeuren TJ; Vanhoutte PM
    J Pharmacol Exp Ther; 1978 Dec; 207(3):936-49. PubMed ID: 215746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha adrenergic receptors in beef aortic membranes characterised by [3H] dihydroergocryptine binding.
    Carman-Krzan M
    Arch Int Pharmacodyn Ther; 1980 Aug; 246(2):237-50. PubMed ID: 6254455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversal of hypertension by transplants and lipid extracts of cultured renomedullary interstitial cells.
    Muirhead EE; Rightsel WA; Leach BE; Byers LW; Pitcock JA; Brooks B
    Lab Invest; 1977 Feb; 36(2):162-72. PubMed ID: 839732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypotensive effects of eugenosedin-A with serotonin, alpha- and beta-adrenoceptor antagonistic activities in spontaneously hypertensive and normotensive rats.
    Shen KP; Chiu CC; Chen SJ; Chen IJ; Wu BN
    Pharmacology; 2004 Jun; 71(2):91-101. PubMed ID: 15118348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular pharmacology of alpha adrenergic receptors: utilization of [3H]dihydroergocryptine binding in the study of pharmacological receptor alterations.
    Williams LT; Lefkowitz RJ
    Mol Pharmacol; 1977 Mar; 13(2):304-13. PubMed ID: 192992
    [No Abstract]   [Full Text] [Related]  

  • 15. Two subpopulations of alpha 1-adrenergic receptors with high and low affinity for agonists: short-term exposure to agonists reduced the high-affinity sites.
    Fratelli M; Marasco O; De Blasi A
    Biochim Biophys Acta; 1987 Aug; 930(1):87-96. PubMed ID: 3040117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal alpha-1 and alpha-2 adrenergic receptors: biochemical and pharmacological correlations.
    Schmitz JM; Graham RM; Sagalowsky A; Pettinger WA
    J Pharmacol Exp Ther; 1981 Nov; 219(2):400-6. PubMed ID: 6270306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha 1-adrenergic receptor blockade reduces afferent and efferent glomerular arteriolar resistances in SHR.
    Uchino K; Nishikimi T; Frohlich ED
    Am J Physiol; 1991 Sep; 261(3 Pt 2):R576-80. PubMed ID: 1679607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the postsynaptic alpha-adrenoceptor in isolated feline cerebral arteries.
    Skärby T; Andersson KE; Edvinsson L
    Acta Physiol Scand; 1981 May; 112(1):105-7. PubMed ID: 6116377
    [No Abstract]   [Full Text] [Related]  

  • 19. Renin and aldosterone secretion in pheochromocytoma. Effect of chronic alpha-adrenergic receptor blockade.
    Vetter H; Vetter W; Warnholz C; Bayer JM; Käser H; Vielhaber K; Krück F
    Am J Med; 1976 May; 60(6):866-71. PubMed ID: 14500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effect of calcium antagonist drugs on vasoconstriction induced by vascular alpha 2-adrenoceptor stimulation.
    van Zwieten PA; Timmermans PB; Thoolen MJ; Wilffert B; De Jonge A
    Am J Cardiol; 1986 Feb; 57(7):11D-15D. PubMed ID: 2869674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.